Evidence map›Paper›PMID 27207650›Full record

ArticleCarcinogenesis2016

Genome-wide association study of colorectal cancer in Hispanics.

Stephanie L Schmit, Fredrick R Schumacher, Christopher K Edlund, David V Conti, Ugonna Ihenacho, Peggy Wan, David Van Den Berg, Graham Casey, Barbara K Fortini, Heinz-Josef Lenz and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. The Phylum Fusobacteriota Is Associated with Colorectal Cancer-Specific Mortality: Results from the Translational Research Program in Cancer Differences across Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Article
  4. The Translational Research Program in Cancer Differences across Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evolutionary Origins of Metabolic Reprogramming in Cancer.International journal of molecular sciences · 2022
    Review
  12. Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress?Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Novel Common Genetic Susceptibility Loci for Colorectal Cancer.Journal of the National Cancer Institute · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 3 countries.

Stephanie L SchmitDepartment of Preventive Medicine.
Fredrick R SchumacherDepartment of Preventive Medicine.
Christopher K EdlundDepartment of Preventive Medicine.
David V ContiDepartment of Preventive Medicine.
Ugonna IhenachoDepartment of Preventive Medicine.
Peggy WanDepartment of Preventive Medicine.
David Van Den BergDepartment of Preventive Medicine.
Graham CaseyDepartment of Preventive Medicine.
Barbara K FortiniDepartment of Biology, Claremont McKenna College, Claremont, CA 91711, USA.
Heinz-Josef LenzDepartment of Preventive Medicine.
Teresa Tusié-LunaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, 14000 México City, México.
Carlos A Aguilar-SalinasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, 14000 México City, México.
Hortensia Moreno-MacíasUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Alicia Huerta-ChagoyaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, 14000 México City, México.
María Luisa Ordóñez-SánchezUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Rosario Rodríguez-GuillénUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Ivette Cruz-BautistaUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Maribel Rodríguez-TorresUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Linda Liliana Muñóz-HernándezUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Olimpia Arellano-CamposInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, 14000 México City, México.
Donají GómezUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Ulices AlvirdeUniversidad Autónoma Metropolitana, Tlalpan 14387, México City, México.
Clicerio González-VillalpandoUnidad de Investigación en Diabetes, Instituto Nacional de Salud Pública, México City, México.
María Elena González-VillalpandoCentro de Estudios en Diabetes, 01120 México City, México and.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA.
Christopher A HaimanDepartment of Preventive Medicine.
Jane C FigueiredoDepartment of Preventive Medicine.
Universidad Autónoma Metropolitana · MXGeneral Department of Preventive Medicine · VNInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversity of Southern California · USClaremont McKenna College · USInstituto Nacional de Salud Pública · MXMoffitt Cancer Center · USUniversity of Hawaiʻi at Mānoa · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Transdisciplinary Studies of Genetic Variation in Colorectal CancerU19CA148107 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GRUBER, STEPHEN B · 2010 to 2014
$11.1M
Training Grant in Genomic Analysis and InterpretationT32ES013678 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAUDERMAN, WILLIAM JAMES, MCCONNELL, ROB S · 2006 to 2023
$5.6M
Adding Hispanics to Ongoing GWAS in Colorectal CancerR01CA155101 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FIGUEIREDO, JANE C. · 2011 to 2015
$4.5M
Incorporating intermediate biomarkers of folate with colorectal cancerR01CA140561 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, DAVID V, SCHUMACHER, FREDRICK RAY · 2011 to 2015
$1.9M
Imputation-based approach to identify low frequency variants in prostate cancerU01CA188392 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SCHUMACHER, FREDRICK RAY · 2014 to 2016
$1.9M
A Multiethnic Genome-Wide Scan of Prostate CancerU01HG004726 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAIMAN, CHRISTOPHER ALAN · 2008 to 2009
$1.2M
NCI NIH HHS P30 CA014089NCI NIH HHS R01 CA140561NCI NIH HHS R01 CA155101NCI NIH HHS U01 CA188392NCI NIH HHS U19 CA148107NHGRI NIH HHS U01 HG004726NIEHS NIH HHS T32 ES013678
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified 58 susceptibility alleles across 37 regions associated with the risk of colorectal cancer (CRC) with P < 5×10(-8) Most studies have been conducted in non-Hispanic whites and East Asians; however, the generalizability of these findings and the potential for ethnic-specific risk variation in Hispanic and Latino (HL) individuals have been largely understudied. We describe the first GWAS of common genetic variation contributing to CRC risk in HL (1611 CRC cases and 4330 controls). We also examine known susceptibility alleles and implement imputation-based fine-mapping to identify potential ethnicity-specific association signals in known risk regions. We discovered 17 variants across 4 independent regions that merit further investigation due to suggestive CRC associations (P < 1×10(-6)) at 1p34.3 (rs7528276; Odds Ratio (OR) = 1.86 [95% confidence interval (CI): 1.47-2.36); P = 2.5×10(-7)], 2q23.3 (rs1367374; OR = 1.37 (95% CI: 1.21-1.55); P = 4.0×10(-7)), 14q24.2 (rs143046984; OR = 1.65 (95% CI: 1.36-2.01); P = 4.1×10(-7)) and 16q12.2 [rs142319636; OR = 1.69 (95% CI: 1.37-2.08); P=7.8×10(-7)]. Among the 57 previously published CRC susceptibility alleles with minor allele frequency ≥1%, 76.5% of SNPs had a consistent direction of effect and 19 (33.3%) were nominally statistically significant (P < 0.05). Further, rs185423955 and rs60892987 were identified as novel secondary susceptibility variants at 3q26.2 (P = 5.3×10(-5)) and 11q12.2 (P = 6.8×10(-5)), respectively. Our findings demonstrate the importance of fine mapping in HL. These results are informative for variant prioritization in functional studies and future risk prediction modeling in minority populations.

Indexed as

Genetic Predisposition to DiseaseAgedAllelesCohort StudiesColorectal NeoplasmsFemaleGenetics, PopulationGenetic VariationGenome-Wide Association StudyHispanic or LatinoHumansMaleMiddle Aged

Identifiers

PMID27207650
PMCPMC4876992
OpenAlexW2336919895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.